Latest / Community Health Media
This Moment in Medicine: T-DXd in Early HER2+ BC with Dr. Michelina Cairo
Where should T-DXd fit in the treatment of high-risk, early-stage HER2-positive breast cancer?
At This Moment in Medicine, hosted by Community Health Media, Dr. Michelina Cairo reviews the latest data from DESTINY-Breast11 and DESTINY-Breast05, examining how trastuzumab deruxtecan (T-DXd) could reshape treatment in both the neoadjuvant and adjuvant settings.
From pathologic complete response and invasive disease-free survival to ILD risk and treatment sequencing, the presentation explores how clinicians might balance efficacy, toxicity, and individual recurrence risk as T-DXd moves into…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.